Machine learning predicts prognosis in patients with gastroenteropancreatic neuroendocrine tumors with liver metastases.
Journal:
Discover oncology
Published Date:
May 12, 2025
Abstract
BACKGROUND: Patients with gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) and liver metastases typically exhibit poor prognoses. However, accurate survival prediction models remain insufficient. This study aimed to develop machine learning-based models to predict the 1-year, 3-year, and 5-year overall survival in these patients.
Authors
Keywords
No keywords available for this article.